Correction: Assessment of urate-lowering therapies on lipid metabolism and kidney function in nondialysis chronic kidney disease patients: 12 months multicenter cohort study | Synapse
March 3, 2026Open Access
Correction: Assessment of urate-lowering therapies on lipid metabolism and kidney function in nondialysis chronic kidney disease patients: 12 months multicenter cohort study
Key Points
Urine function and lipid metabolism potentially improve with urate-lowering therapies in chronic kidney disease patients.
Key findings indicate an overall improvement in kidney function over 12 months of assessment.
Multicenter cohort study sought to evaluate the effects of urate-lowering therapies on patients' health outcomes.
Implications highlight the importance of monitoring these therapies in chronic kidney disease management.
Abstract
This corrects the article DOI: 10.3389/fendo.2025.1592290..